Texas 2019 - 86th Regular

Texas House Bill HB3284 Latest Draft

Bill / Enrolled Version Filed 05/27/2019

                            H.B. No. 3284


 AN ACT
 relating to the prescribing and dispensing of controlled substances
 under the Texas Controlled Substances Act; authorizing a fee;
 providing for administrative penalties; creating criminal
 offenses.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 481.076, Health and Safety Code, is
 amended by amending Subsections (a), (f), (g), and (h) and adding
 Subsection (a-6) to read as follows:
 (a)  The board may not permit any person to have access to
 information submitted to the board under Section 481.074(q) or
 481.075 except:
 (1)  the board, the Texas Medical Board, the Texas
 Department of Licensing and Regulation, with respect to the
 regulation of podiatrists [State Board of Podiatric Medical
 Examiners], the State Board of Dental Examiners, the State Board of
 Veterinary Medical Examiners, the Texas Board of Nursing, or the
 Texas Optometry Board for the purpose of:
 (A)  investigating a specific license holder; or
 (B)  monitoring for potentially harmful
 prescribing or dispensing patterns or practices under Section
 481.0762;
 (2)  an [authorized officer or member of the department
 or] authorized employee of the board engaged in the administration,
 investigation, or enforcement of this chapter or another law
 governing illicit drugs in this state or another state;
 (3)  the department or other [on behalf of a] law
 enforcement or prosecutorial official engaged in the
 administration, investigation, or enforcement of this chapter or
 another law governing illicit drugs in this state or another state,
 if the board is provided a warrant, subpoena, or other court order
 compelling the disclosure;
 (4)  a medical examiner conducting an investigation;
 (5)  provided that accessing the information is
 authorized under the Health Insurance Portability and
 Accountability Act of 1996 (Pub. L. No. 104-191) and regulations
 adopted under that Act:
 (A)  a pharmacist or a pharmacy technician, as
 defined by Section 551.003, Occupations Code, acting at the
 direction of a pharmacist; or
 (B)  a practitioner who:
 (i)  is a physician, dentist, veterinarian,
 podiatrist, optometrist, or advanced practice nurse or is a
 physician assistant described by Section 481.002(39)(D) or an
 employee or other agent of a practitioner acting at the direction of
 a practitioner; and
 (ii)  is inquiring about a recent Schedule
 II, III, IV, or V prescription history of a particular patient of
 the practitioner;
 (6)  a pharmacist or practitioner who is inquiring
 about the person's own dispensing or prescribing activity; [or]
 (7)  one or more states or an association of states with
 which the board has an interoperability agreement, as provided by
 Subsection (j);
 (8)  a health care facility certified by the federal
 Centers for Medicare and Medicaid Services; or
 (9)  the patient, the patient's parent or legal
 guardian, if the patient is a minor, or the patient's legal
 guardian, if the patient is an incapacitated person, as defined by
 Section 1002.017(2), Estates Code, inquiring about the patient's
 prescription record, including persons who have accessed that
 record.
 (a-6)  A patient, the patient's parent or legal guardian, if
 the patient is a minor, or the patient's legal guardian, if the
 patient is an incapacitated person, as defined by Section
 1002.017(2), Estates Code, is entitled to a copy of the patient's
 prescription record as provided by Subsection (a)(9), including a
 list of persons who have accessed that record, if a completed
 patient data request form and any supporting documentation required
 by the board is submitted to the board. The board may charge a
 reasonable fee for providing the copy. The board shall adopt rules
 to implement this subsection, including rules prescribing the
 patient data request form, listing the documentation required for
 receiving a copy of the prescription record, and setting the fee.
 (f)  If the board accesses [director permits access to]
 information under Subsection (a)(2) relating to a person licensed
 or regulated by an agency listed in Subsection (a)(1), the board
 [director] shall notify and cooperate with that agency regarding
 the disposition of the matter before taking action against the
 person, unless the board [director] determines that notification is
 reasonably likely to interfere with an administrative or criminal
 investigation or prosecution.
 (g)  If the board provides [director permits] access to
 information under Subsection (a)(3) relating to a person licensed
 or regulated by an agency listed in Subsection (a)(1), the board
 [director] shall notify that agency of the disclosure of the
 information not later than the 10th working day after the date the
 information is disclosed.
 (h)  If the board [director] withholds notification to an
 agency under Subsection (f), the board [director] shall notify the
 agency of the disclosure of the information and the reason for
 withholding notification when the board [director] determines that
 notification is no longer likely to interfere with an
 administrative or criminal investigation or prosecution.
 SECTION 2.  Section 481.0766, Health and Safety Code, is
 amended by adding Subsection (c) to read as follows:
 (c)  The board shall make the information reported under
 Subsection (a) available to the State Board of Veterinary Medical
 Examiners for the purpose of routine inspections and
 investigations.
 SECTION 3.  Subchapter C, Chapter 481, Health and Safety
 Code, is amended by adding Sections 481.0767, 481.0768, and
 481.0769 to read as follows:
 Sec. 481.0767.  ADVISORY COMMITTEE. (a)  The board shall
 establish an advisory committee to make recommendations regarding
 information submitted to the board and access to that information
 under Sections 481.074, 481.075, 481.076, and 481.0761, including
 recommendations for:
 (1)  operational improvements to the electronic system
 that stores the information, including implementing best practices
 and improvements that address system weaknesses and workflow
 challenges;
 (2)  resolutions to identified data concerns;
 (3)  methods to improve data accuracy, integrity, and
 security and to reduce technical difficulties; and
 (4)  the addition of any new data set or service to the
 information submitted to the board or the access to that
 information.
 (b)  The board shall appoint the following members to the
 advisory committee:
 (1)  a physician licensed in this state who practices
 in pain management;
 (2)  a physician licensed in this state who practices
 in family medicine;
 (3)  a physician licensed in this state who performs
 surgery;
 (4)  a physician licensed in this state who practices
 in emergency medicine at a hospital;
 (5)  a physician licensed in this state who practices
 in psychiatry;
 (6)  an oral and maxillofacial surgeon;
 (7)  a physician assistant or advanced practice
 registered nurse to whom a physician has delegated the authority to
 prescribe or order a drug;
 (8)  a pharmacist working at a chain pharmacy;
 (9)  a pharmacist working at an independent pharmacy;
 (10)  an academic pharmacist; and
 (11)  two representatives of the health information
 technology industry, at least one of whom is a representative of a
 company whose primary line of business is electronic medical
 records.
 (c)  Members of the advisory committee serve three-year
 terms. Each member shall serve until the member's replacement has
 been appointed.
 (d)  The advisory committee shall annually elect a presiding
 officer from its members.
 (e)  The advisory committee shall meet at least two times a
 year and at the call of the presiding officer or the board.
 (f)  A member of the advisory committee serves without
 compensation but may be reimbursed by the board for actual expenses
 incurred in performing the duties of the advisory committee.
 Sec. 481.0768.  ADMINISTRATIVE PENALTY:  DISCLOSURE OR USE
 OF INFORMATION.  (a)  A person authorized to receive information
 under Section 481.076(a) may not disclose or use the information in
 a manner not authorized by this subchapter or other law.
 (b)  A regulatory agency that issues a license,
 certification, or registration to a prescriber or dispenser shall
 periodically update the administrative penalties, or any
 applicable disciplinary guidelines concerning the penalties,
 assessed by that agency for conduct that violates Subsection (a).
 (c)  The agency shall set the penalties in an amount
 sufficient to deter the conduct.
 Sec. 481.0769.  CRIMINAL OFFENSES RELATED TO PRESCRIPTION
 INFORMATION. (a) A person authorized to receive information under
 Section 481.076(a) commits an offense if the person discloses or
 uses the information in a manner not authorized by this subchapter
 or other law.
 (b)  A person requesting information under Section
 481.076(a-6) commits an offense if the person makes a material
 misrepresentation or fails to disclose a material fact in the
 request for information under that subsection.
 (c)  An offense under Subsection (a) is a Class A
 misdemeanor.
 (d)  An offense under Subsection (b) is a Class C
 misdemeanor.
 SECTION 4.  Section 801.307, Occupations Code, is amended by
 adding Subsection (a-1) to read as follows:
 (a-1)  The board by rule shall require a veterinarian to
 complete two hours of continuing education related to opioid abuse
 and controlled substance diversion, inventory, and security every
 two years to renew a license to practice veterinary medicine.
 SECTION 5.  Section 481.003(a), Health and Safety Code, is
 amended to read as follows:
 (a)  The director may adopt rules to administer and enforce
 this chapter, other than Sections 481.073, 481.074, 481.075,
 481.076, 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, [and]
 481.0766, 481.0767, 481.0768, and 481.0769.  The board may adopt
 rules to administer Sections 481.073, 481.074, 481.075, 481.076,
 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, [and] 481.0766,
 481.0767, 481.0768, and 481.0769.
 SECTION 6.  Section 481.128(a), Health and Safety Code, is
 amended to read as follows:
 (a)  A registrant or dispenser commits an offense if the
 registrant or dispenser knowingly:
 (1)  distributes, delivers, administers, or dispenses
 a controlled substance in violation of Subchapter C [Sections
 481.070-481.075];
 (2)  manufactures a controlled substance not
 authorized by the person's Federal Drug Enforcement Administration
 registration or distributes or dispenses a controlled substance not
 authorized by the person's registration to another registrant or
 other person;
 (3)  refuses or fails to make, keep, or furnish a
 record, report, notification, order form, statement, invoice, or
 information required by this chapter;
 (4)  prints, manufactures, possesses, or produces an
 official prescription form without the approval of the board;
 (5)  delivers or possesses a counterfeit official
 prescription form;
 (6)  refuses an entry into a premise for an inspection
 authorized by this chapter;
 (7)  refuses or fails to return an official
 prescription form as required by Section 481.075(k);
 (8)  refuses or fails to make, keep, or furnish a
 record, report, notification, order form, statement, invoice, or
 information required by a rule adopted by the director or the board;
 or
 (9)  refuses or fails to maintain security required by
 this chapter or a rule adopted under this chapter.
 SECTION 7.  Section 481.129(a), Health and Safety Code, is
 amended to read as follows:
 (a)  A person commits an offense if the person knowingly:
 (1)  distributes as a registrant or dispenser a
 controlled substance listed in Schedule I or II, unless the person
 distributes the controlled substance as authorized under the
 federal Controlled Substances Act (21 U.S.C. Section 801 et seq.);
 (2)  uses in the course of manufacturing, prescribing,
 or distributing a controlled substance a Federal Drug Enforcement
 Administration registration number that is fictitious, revoked,
 suspended, or issued to another person;
 (3)  issues a prescription bearing a forged or
 fictitious signature;
 (4)  uses a prescription issued to another person to
 prescribe a Schedule II controlled substance;
 (5)  possesses, obtains, or attempts to possess or
 obtain a controlled substance or an increased quantity of a
 controlled substance:
 (A)  by misrepresentation, fraud, forgery,
 deception, or subterfuge;
 (B)  through use of a fraudulent prescription
 form; [or]
 (C)  through use of a fraudulent oral or
 telephonically communicated prescription; or
 (D)  through the use of a fraudulent electronic
 prescription; or
 (6)  furnishes false or fraudulent material
 information in or omits material information from an application,
 report, record, or other document required to be kept or filed under
 this chapter.
 SECTION 8.  Section 554.051(a-1), Occupations Code, is
 amended to read as follows:
 (a-1)  The board may adopt rules to administer Sections
 481.073, 481.074, 481.075, 481.076, 481.0761, 481.0762, 481.0763,
 481.0764, 481.0765, [and] 481.0766, 481.0767, 481.0768, and
 481.0769, Health and Safety Code.
 SECTION 9.  Section 565.003, Occupations Code, is amended to
 read as follows:
 Sec. 565.003.  ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING
 APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless
 compliance would violate the pharmacy or drug statutes or rules in
 the state in which the pharmacy is located, the board may discipline
 an applicant for or the holder of a nonresident pharmacy license if
 the board finds that the applicant or license holder has failed to
 comply with:
 (1)  Subchapter C, Chapter 481 [Section 481.074 or
 481.075], Health and Safety Code;
 (2)  Texas substitution requirements regarding:
 (A)  the practitioner's directions concerning
 generic substitution;
 (B)  the patient's right to refuse generic
 substitution; or
 (C)  notification to the patient of the patient's
 right to refuse substitution;
 (3)  any board rule relating to providing drug
 information to the patient or the patient's agent in written form or
 by telephone; or
 (4)  any board rule adopted under Section 554.051(a)
 and determined by the board to be applicable under Section
 554.051(b).
 SECTION 10.  Sections 481.076(a-3), (a-4), and (a-5), Health
 and Safety Code, are repealed.
 SECTION 11.  To the extent of any conflict, this Act prevails
 over another Act of the 86th Legislature, Regular Session, 2019,
 relating to nonsubstantive additions to and corrections in enacted
 codes.
 SECTION 12.  Notwithstanding Section 24, Chapter 485 (H.B.
 2561), Acts of the 85th Legislature, Regular Session, 2017, Section
 481.0764(a), Health and Safety Code, as added by that Act, applies
 only to:
 (1)  a prescriber, other than a veterinarian, who
 issues a prescription for a controlled substance on or after March
 1, 2020; or
 (2)  a person authorized by law to dispense a
 controlled substance, other than a veterinarian, who dispenses a
 controlled substance on or after March 1, 2020.
 SECTION 13.  Section 481.0768(a), Health and Safety Code, as
 added by this Act, applies only to conduct that occurs on or after
 the effective date of this Act.
 SECTION 14.  Section 801.307(a-1), Occupations Code, as
 added by this Act, applies only to the renewal of a license to
 practice veterinary medicine on or after September 1, 2020. The
 renewal of a license before that date is governed by the law in
 effect immediately before the effective date of this Act, and the
 former law is continued in effect for that purpose.
 SECTION 15.  This Act takes effect September 1, 2019.
 ______________________________ ______________________________
 President of the Senate Speaker of the House
 I certify that H.B. No. 3284 was passed by the House on May
 10, 2019, by the following vote:  Yeas 136, Nays 3, 1 present, not
 voting; that the House refused to concur in Senate amendments to
 H.B. No. 3284 on May 24, 2019, and requested the appointment of a
 conference committee to consider the differences between the two
 houses; and that the House adopted the conference committee report
 on H.B. No. 3284 on May 26, 2019, by the following vote:  Yeas 139,
 Nays 4, 1 present, not voting.
 ______________________________
 Chief Clerk of the House
 I certify that H.B. No. 3284 was passed by the Senate, with
 amendments, on May 22, 2019, by the following vote:  Yeas 30, Nays
 1; at the request of the House, the Senate appointed a conference
 committee to consider the differences between the two houses; and
 that the Senate adopted the conference committee report on H.B. No.
 3284 on May 26, 2019, by the following vote:  Yeas 30, Nays 1.
 ______________________________
 Secretary of the Senate
 APPROVED: __________________
 Date
 __________________
 Governor